Sun, Aug 06, 2017 - Page 5 News List

Fertility clinic told to stop marketing


US regulators on Friday told a New York fertility doctor to stop marketing an experimental procedure that uses DNA from three people — a mother, a father and an egg donor — to avoid certain genetic diseases.

The doctor, John Zhang, used the technique to help a Jordanian couple have a baby boy last year.

According to the US Food and Drug Administration (FDA), Zhang said his companies would not use the technology in the US again without permission, yet they continue to promote it.

The procedure is not approved in the US and the US Congress has barred the FDA from even reviewing proposals to conduct such experiments.

A receptionist at Zhang’s New Hope Fertility Clinic in New York said on Friday that no one was available to comment.

Zhang heads the clinic and a related company, Darwin Life Inc.

New Hope’s Web site touts having achieved the “first live birth” using the technology, along with other advanced fertility treatments it offers.

The FDA’s letter to Zhang cites several other marketing claims, including a reference to “the first proven treatment for certain genetic disorders.”

The birth of the boy was disclosed in September last year.

The mother carries DNA that could have given her child Leigh syndrome, a severe neurological disorder that usually kills within a few years of birth.

The experimental technique involves removing some of the mother’s DNA from an egg and leaving the disease-causing DNA behind. The healthy DNA gets slipped into a donor’s egg, which is then fertilized.

As a result, the baby inherits DNA from both parents and the egg donor, producing what has been called “three-parent babies” — although the DNA contribution from the egg donor is small.

People carry DNA in two places, the nucleus of the cell and in structures called mitochondria, which lie outside the nucleus. The technique is designed to transfer only DNA of the nucleus to the donor egg.

A medical journal report on the case said the procedure was done at the New York clinic and the embryo was taken to Mexico, where it was implanted.

The procedure is not illegal in Mexico.

Last year, a report from a panel of US government advisers said it is ethical to begin testing this approach in pregnancy, as long as the first studies follow strict safety steps.

The studies must include women at high risk of passing on a severe disease and, at first, implant only male embryos, so the alterations would not pass to future generations.

This story has been viewed 1440 times.

Comments will be moderated. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned.

TOP top